Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV
Por um escritor misterioso
Descrição
Race for a Coronavirus Vaccine
Design, immunogenicity and efficacy of a Pan-SARS-CoV-2 synthetic DNA vaccine
Inovio to start Phase III efficacy trial of Covid-19 vaccine
Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic - Wang - 2022 - Exploration - Wiley Online Library
The 2020 race towards SARS-CoV-2 specific vaccines
An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19), Cellular & Molecular Biology Letters
SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines
Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study) - eClinicalMedicine
Race for a Coronavirus Vaccine
Frontiers COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations
An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations - Bulent Kantarcioglu, Omer Iqbal, Joseph Lewis, Charles A. Carter, Meharvan Singh, Fabio Lievano
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
EX-99.1
Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS -CoV-2
de
por adulto (o preço varia de acordo com o tamanho do grupo)
